A fast (organically) growing revenue generating company with a solid product, strong and experienced management team, high gross margins, a clear path to profitability and a very strong reputation + an exciting R&D pipeline (not exposed to the LCD changes)
Yet it's valued pretty much akin to that of a "shell", as you say. Either the market knows something that everyone here (+ the E&P guys and the management who are actively expanding production capacity) doesn't, or the market is seriously mistaken with its valuation of this company and we are due for an enormous rerate. I'm guessing it's the latter...
Time will tell
Nova Eye Medical (EYE) Discussion, page-1092
-
- There are more pages in this discussion • 2,096 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.10M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.5¢ | 21.0¢ | $45.70K | 217.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2722 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 57356 | 2 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| EYE (ASX) Chart |